Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Inborn errors of immunity & corresponding protein interactions

Antifungal drug-delivery using micelles

HELLO- A method based on DNN architecture

Inborn errors of immunity & corresponding protein interactions
  • BiotechToday
  • World

Inborn errors of immunity & corresponding protein interactions

bioxone August 18, 2021August 18, 2021

Avani Dave, Jai Hind College

Inborn errors of immunity (IEI) are a group of approximately 400 monogenic diseases characterized by recurring, severe, or uncommon infections, as well as autoimmunity and autoinflammation. The synthesis of the clinical phenotype, the findings of immunological testing, and the results of genetic testing have identified the main pathogenic mutations required to make a diagnosis in these individuals(s). 

The technique of finding genetic variations has become much easier because of whole-exome and genome sequencing. When this method can’t locate a known pathogenic variation or even a known IEI gene, it shifts gears to see if a novel gene may be to blame for the illness phenotype. It’s an unresolved challenge to narrow down the list of thousands of genes and tens of thousands of variations in “non-clinical” genes/genes that haven’t yet been recognized as significant for a human illness. The list of variations can be whittled down to a few hundred genes by filtering out those that are prevalent in human populations. However, selecting genes and verifying their roles is a time-consuming procedure that follows this stage.

Every year, nearly a third of a dozen new IEI genes are identified. Although the correct gene is found, the procedure of verifying the biochemical and immunological effects of the discovered variant(s) is clearly defined, as time-consuming. A recent study conducted by Khan, H. A., et al. presents a list of IEI-related genes compiled by connecting known IEI proteins with novel IEI proteins.

Discussion: 

Using open-source datasets of protein-protein interactions, post-translational modifications, and transcriptional regulation, a new list of genes was delineated by connecting known IEI genes to new ones. The researchers further looked at the tolerance of genetic diversity in this new list of 2,530 IEI-related genes, as well as their expression levels in different immune cell types. This study presents a fresh list of potential genes that may play a role in as-yet-undiscovered IEIs by combining genes obtained from protein interactions of known IEI genes with transcriptional data. However, the lists do not address the issue of identifying non-redundant genes as the source of immunodeficiencies. This issue might be solved with better databases of immunological networks and tissue annotation.

The future prospects of the study:

In summary, the technique described during the study offers both a global and local perspective of proteins that may be important to query in future immunodeficiency research by combining 1:1 annotated protein interaction with broader, un-annotated protein interaction pathways. This study has enhanced the chance of genes from redundant, non-specific immune pathways being eliminated by further trimming the lists for cell-type expression. 

Notably, the findings discovered that a high probability of loss intolerance (pLI) or Gene damage indices (GDI) was ineffective in identifying the pathogenicity of a putatively new IEI gene, particularly those with recessive inheritance patterns. Furthermore, the findings build on prior research by combining transcriptional expression data with the list of IEI candidate genes obtained from protein interactions, ensuring that inquiries are answered based on clinical manifestations (e.g., T-cell lymphopenia) or diagnostic assumptions. This exploratory research in protein interaction is an extremely helpful tool for a comprehensive understanding of the underlying mechanisms.

Also read: Antifungal drug-delivery using micelles

Reference: Khan, H. A., & Butte, M. J. (2021). Expanding the potential genes of inborn errors of immunity through protein interactions. BMC Genomics, 22(1), 618. https://doi.org/10.1186/s12864-021-07909-3

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author’s Info:

Avani Dave is currently in the final year of her bachelor’s degree, majoring in Life Sciences. Holding a good academic and extra-curricular record, she is on a constant journey of acquiring exposure in her field of interest while simultaneously not limiting herself to just that. Avani likes studying Diseases and Syndromes and everything under this umbrella! That being said, she is adept at working across departments and promises to deliver.

LinkedIn – https://www.linkedin.com/avani-dave/

Publications in BioXone:

  • Dave, A. (2021). Hirschsprung disease patients show novel gene revelations! BioXone. https://bioxone.in/news/worldnews/hirschsprung-disease-patients-show-novel-gene-revelations/
  • Dave, A. (2021). Autism Spectrum Disorder & its occurrence in Preterm Infants. BioXone. https://bioxone.in/news/autism-spectrum-disorder-its-occurrence-in-preterm-infants/
  • Dave, A. (2021). HEI10: How do sex cells receive the right genetic mix? BioXone. https://bioxone.in/news/worldnews/hei10-how-do-sex-cells-receive-the-right-genetic-mix/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged chromosomal aberrations Clinical manifestations Exome genome immunity immunodeficiency inflammation pathogenicity proteomics transcriptomics

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

HELLO- A method based on DNN architecture

bioxone August 18, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Variant calling is the process by which we can identify variants in the sequence data provided. Variant calling has a major application in modern bioinformatics. It helps in discovering the underlying traits of Mendelian diseases, in understanding the individual’s susceptibility to cancer, and also to study genetic […]

Hello

Related Post

  • BiotechToday
  • World

Pre-exposure Prophylaxis trajectories for targeting AIDS

BioTech Today July 20, 2021July 21, 2021

Kanikah Mehndiratta, MSc, University of Glasgow Pre-exposure Prophylaxis (PrEP) is a national program by the US government that provides medication with anti-retroviral drugs. It is specifically intended for adults and adolescents that are at higher risk of getting infected with the Human Immuno Virus (HIV) in the future. It is a preventative approach in which […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

BRAFi-addicted melanoma cells: proteomics and phosphoproteomics profiling

bioxone August 6, 2021August 5, 2021

Husna, Amity University Kolkata What is a BRAF inhibitor and what is its role? BRAF is a gene that is present on chromosome 7q34. It encodes a protein that has the ability to regulate the MAP kinase/ERKs-signaling pathway. These pathways have a crucial role in regulating cell division, differentiation, and the growth and proliferation of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

The discovery of Antarctica 1300 years ago

BioTech Today June 23, 2021June 23, 2021

Anjali Kumari, IILM College of Engineering and Technology The credit for the discovery of Antarctica is typically given to the Europeans but according to new research that is published in the Journal of the Royal Society of New Zealand, the Polynesians discovered Antarctica over 1300 years ago. It is believed that they were among the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy